Boone Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-519,977
Closed -$41.2M – 18
2026
Q2
$41.2M Buy
519,977
+19,455
+4% +$1.46M 9.64% 4
2026
Q1
$37.6M Buy
500,522
+82,689
+20% +$6.53M 11.51% 2
2025
Q4
$33.1M Hold
417,833
– – 10.37% 3
2025
Q3
$27.3M Buy
+417,833
New +$20.4M 8.96% 3

Other funds holding IONS

Boone Capital Management's IONS Position: Q3 2026 in Review

Boone Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 519,977 shares — an estimated $41.2M sold.

Boone Capital Management first reported a position in IONS in Q3 2025 and held it in 4 quarters. The position peaked at $41.2M in Q2 2026. 462 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Boone Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Boone Capital Management sold 519,977 Ionis Pharmaceuticals shares in Q3 2026, an estimated $41.2M.
  • Boone Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Boone Capital Management's Ionis Pharmaceuticals position peaked at $41.2M in Q2 2026.
  • 462 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Boone Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.